#CochraneReview
the-14.com
October 11, 2026 at 10:37 PM
#Vorhofflimmern ist ein unregelmäßiger Herzrhythmus, der unter anderem das #Schlaganfallrisiko erhöht. Welche Nutzen & mögliche Schäden eine #bewegungsbasierten Herz-Rehabilitation für Erwachsene mit Vorhofflimmern hat, untersucht ein #CochraneReview: buff.ly/4j31Cpr
Bewegungsbasierte Herz‐Rehabilitation für Erwachsene mit Vorhofflimmern - Buckley, BJR - 2024 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
buff.ly
January 16, 2025 at 5:02 AM
December 21, 2024 at 12:38 PM
Add name to get this garbage issued by #CochraneReview 2024 retracted! How do people sleep at night putting out such drivel? What? Do their jobs interfere w hip-hop step class or hitting nine on a sunny weekend?

#MEcfs
#doitrightornotatall
#chronicillness
#MEDsky

www.change.org/p/cochrane-w...
Sponsor Cochrane: Withdraw the harmful 2019/2024 Exercise therapy for CFS review · Change.org
www.change.org
January 20, 2025 at 4:56 PM
🎵 Can music improve sleep quality?

A Cochrane review found: listening to prerecorded #music daily for 25–60 minutes over periods of three days-three months led to moderate-certainty evidence of better #sleepquality.

pubmed.ncbi.nlm.nih.gov/36000763/

#EvidenceBasedPractice #CochraneReview
November 4, 2025 at 8:13 PM
Cochrane Review Finds Anti-Amyloid Drugs Offer No Meaningful Benefit for Alzheimer’s and Increase Brain Swelling Risk

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

#alzheimers #amyloid #cochranereview

View full AI summary:
Cochrane Review Finds Anti-Amyloid Drugs Offer No Meaningful Benefit for Alzheimer’s and Increase Brain Swelling Risk
A comprehensive Cochrane systematic review analyzing data from 17 clinical trials involving over 20,000 participants has concluded that anti-amyloid monoclonal antibodies, designed to clear amyloid beta plaques from the brain, provide little to no meaningful clinical benefit for patients with mild cognitive impairment or early-stage Alzheimer’s dementia. The drugs, which successfully reduce amyloid levels, fail to produce noticeable improvements in memory, cognitive function, or disease progression that would be considered relevant in everyday clinical practice. Lead author Francesco Nonino emphasized the distinction between statistical significance in trials and real-world clinical relevance for patients. Safety concerns were also prominent in the findings. The medications were associated with elevated risks of brain swelling (ARIA-E) and bleeding (ARIA-H), often detected only through imaging and not always accompanied by noticeable symptoms. The long-term implications of these side effects remain unclear due to inconsistent reporting across studies. The review challenges the long-held amyloid hypothesis as the primary target for Alzheimer’s treatment. Researchers recommend shifting focus to other biological pathways involved in the disease. Senior author Edo Richard noted the high unmet need for effective therapies, stating that while some existing drugs offer modest benefits, anti-amyloid treatments do not deliver meaningful results and introduce additional risks. The study calls for renewed research efforts into alternative approaches to address this devastating neurodegenerative condition.
killbait.com
May 4, 2026 at 3:00 PM
Ihr erinnert euch ?

Ausgang des Referats:
Keine Folie zur Evidenz
Auf Nachfrage von mir: kein Schadenspotenzial, außer man macht es falsch. Schäden nach Durchführung KÖNNEN NICHT an der Methode liegen.

Okay, wow.

Angeblich gibt's ein Cochranereview, was das belegt. Hatte sie aber nicht mit drin.
Studentin, die nächste Woche ein Referat halten will, will das über ein esoterisches Konzept halten. Ich hab sie darauf hingewiesen, dass ich gerne eine Folie hätte zum Thema Evidenz der Methode.

Will sie eigentlich nicht, weil "die Forschung ist so viel langsamer als die Erfahrung damit"

Okay.😅
June 19, 2024 at 10:02 AM
August 28, 2025 at 7:17 AM
August 26, 2025 at 9:17 AM
August 24, 2025 at 12:38 PM
August 22, 2025 at 7:52 AM
August 20, 2025 at 7:35 AM
August 18, 2025 at 10:40 AM
August 16, 2025 at 10:09 AM
August 14, 2025 at 11:11 AM
August 12, 2025 at 11:06 AM
August 10, 2025 at 11:30 AM
August 7, 2025 at 7:19 AM